Dr. Evgeny Vadimovich Sidorov, MD

Dr. Sidorov practices at Ou Medical Center-The Children's Ho - Rad CT - HOPD in Oklahoma City, Oklahoma.

Dr. Sidorov's NPI, 1417098880, was assigned on February 9, 2007. Dr. Sidorov holds Oklahoma license 24894.

Dr. Sidorov's primary practice is Ou Medical Center-the Children's Ho - Rad CT - HOPD, at 1200 Childrens Ave, Oklahoma City, OK 73104.

Dr. Sidorov's primary practice is Ou Medical Center-The Children's Ho - Rad CT - HOPD in Oklahoma City, Oklahoma. Dr. Sidorov is also affiliated with OU Health University of Oklahoma Medical Center. The medical group on file is OU Health. Dmand AI also links Dr. Sidorov to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sidorov practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Sidorov's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Sidorov is licensed in Oklahoma.

CMS data shows 342 Medicare services from Dr. Sidorov across 6 procedure codes in 2024, for 164 Medicare patients. Medicare paid $27,340 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 164 Medicare patients who saw Dr. Sidorov in 2024. The largest group is 65 to 74, with 62 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sidorov's median patient age at 71, with 54% women.

In 2024, Dr. Sidorov wrote 336 Medicare Part D claims for 55 patients. 63% of them were for generic drugs. CMS names the drug for 195 of them, across 10 drugs with 11 or more claims each, at $124,475 in total drug cost. In 2023, CMS named 174 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 77 out of 100 for Dr. Sidorov for performance year 2024, reported as part of a group. Dr. Sidorov accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sidorov as offering telehealth.

Dmand AI links 34 papers to Dr. Sidorov, published from 2011 to 2025. 2023 was the busiest year, with 5. The most frequent topics are Stroke, Ischemic Stroke and Metabolomics. Dr. Sidorov has published most often in J Stroke Cerebrovasc Dis. Dr. Sidorov's most frequent co-authors are Bappaditya Ray, MD, Sheng Li, MD, PhD and Bradley N. Bohnstedt, MD.

Dmand AI links Dr. Sidorov to 3 clinical trials. Conditions studied include Stroke, Cerebrovascular Disorders and Ischemic Stroke.

CMS Open Payments shows 86 general payments to Dr. Sidorov from 20 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 83% of the total. Allergan Inc. paid the most, $10,724.